Cerebellar magnetic stimulation decreases levodopa-induced dyskinesias in Parkinson disease

Neurology

Volumn 73, Issue 2, 2009, Pages 113-119

  Koch, G ^a,b   Brusa, L ^c   Carrillo, F ^d   Lo Gerfo, E ^b   Torriero, S ^b   Oliveri, M ^a   Mir, P ^d   Caltagirone, C ^a,b   Stanzione, P ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c S EUGENIO HOSPITAL   (Italy)

^d CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA;

AGED; ARTICLE; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; DYSKINESIA; HUMAN; MOTOR CORTEX; PARKINSON DISEASE; PRIORITY JOURNAL; TRANSCRANIAL MAGNETIC STIMULATION; ANALYSIS OF VARIANCE; EVOKED MUSCLE RESPONSE; HOSPITALIZATION; MIDDLE AGED; NERVE CELL INHIBITION; NERVE CELL PLASTICITY; NERVE TRACT; PATHOPHYSIOLOGY; THALAMUS;

AGED; ANALYSIS OF VARIANCE; CEREBELLUM; DYSKINESIA, DRUG-INDUCED; EVOKED POTENTIALS, MOTOR; HUMANS; LEVODOPA; MIDDLE AGED; MOTOR CORTEX; NEURAL INHIBITION; NEURAL PATHWAYS; NEURONAL PLASTICITY; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; THALAMUS; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 68149126428     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181ad5387     Document Type: Article

References (40)

1. Fahn S. The spectrum of levodopa-induced dyskinesias. Ann Neurol 2000;47:S2-S9.
2. Rascol O, Brooks DJ, Korczyn AD, et al. A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. 056 Study Group. N Engl J Med 2000;342:1484-1491.
3. Bezard E, Brotchie JM, Gross CE. Pathophysiology of levodopa-induced dyskinesia: potential for new therapies. Nat Rev Neurosci 2001;2:577-588.
4. Guridi J, Obeso JA, Rodriguez-Oroz MC, et al. Levodopa-induced dyskinesia and stereotactic surgery for Parkinson's disease. Neurosurgery 2008;62:311-323.
5. Lozano AM, Lang AE, Levy R, et al. Neuronal recordings in Parkinson's disease patients with dyskinesias induced by apomorphine. Ann Neurol 2000;47:S141-S146.
6. Brooks DJ, Piccini P, Turjanski N, Samuel M. Neuroimaging of dyskinesia. Ann Neurol 2000;47:S154-S158.
7. Koch G, Brusa L, Caltagirone C, et al. rTMS of supplementary motor area modulates therapy-induced dyskinesias in Parkinson disease. Neurology 2005;65:623-625.
8. Brusa L, Versace V, Koch G, et al. Low frequency rTMS of the SMA transiently ameliorates peak-dose LID in Parkinson's disease. Clin Neurophysiol 2006;117:1917-1921.
9. Wagle-Shukla A, Angel MJ, Zadikoff C, et al. Low-frequency repetitive transcranial magnetic stimulation for treatment of levodopa-induced dyskinesias. Neurology 2007;68:704-705.
10. Centonze D, Bernardi G, Koch G. Mechanisms of disease: basic-research-driven investigations in humans - the case of hyperkinetic disorders. Nat Clin Pract Neurol 2007;3:572-580.
11. Yu H, Sternad D, Corcos DM, Vaillancourt DE. Role of hyperactive cerebellum and motor cortex in Parkinson's disease. Neuroimage 2007;35:222-233.
12. Lewis MM, Slagle CG, Smith AB, et al. Task specific influences of Parkinson's disease on the striato-thalamocortical and cerebello-thalamo- cortical motor circuitries. Neuroscience 2007;147:224-235.
13. Ballanger B, Baraduc P, Broussolle E, et al. Motor urgency is mediated by the contralateral cerebellum in Parkinson's disease. J Neurol Neurosurg Psychiatry 2008;79:1110-1116.
14. Hurley MJ, Mash DC, Jenner P. Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinson's disease examined by RT-PCR. Eur J Neurosci 2003;18:2668-2672.
15. Starr PA, Vitek JL, Bakay RA. Ablative surgery and deep brain stimulation for Parkinson's disease. Neurosurgery 1998;43:989-1015.
16. Fukuda M, Mentis MJ, Ma Y, et al. Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: a PET study of resting-state glucose metabolism. Brain 2001;124:1601-1609.
17. Nimura T, Ando T, Yamaguchi K, et al. The role of sigma-receptors in levodopa-induced dyskinesia in patients with advanced Parkinson disease: a positron emission tomography study. J Neurosurg 2004;100:606-610.
18. Huang YZ, Edwards MJ, Rounis E, et al. Theta burst stimulation of the human motor cortex. Neuron 2005;45:201-206.
19. Koch G, Mori F, Marconi B, et al. Changes in intracortical circuits of the human motor cortex following theta burst stimulation of the lateral cerebellum. Clinical Neurophysiol 2008;119:2559-2569.
20. Kujirai T, Caramia MD, Rothwell JC, et al. Corticocortical inhibition in human motor cortex. J Physiol 1993;471:501-519.
21. Rothwell JC. Techniques and mechanisms of action of transcranial stimulation of the human motor cortex. J Neurosci Methods 1997;74:113-122.
22. Valls-Solé J, Pascual-Leone A, Wassermann EM, Hallett M. Human motor evoked responses to paired transcranial magnetic stimuli. Electroencephalogr Clin Neurophysiol 1992;85:355-364.
23. Tsai CH, Chang FC, Lu CS, et al. Pallidotomy effect on the cortical excitability in patients with severe Parkinson's disease. Mov Disord 2005;20:463-470.
24. Strafella A, Ashby P, Lang AE. Pallidotomy increases cortical inhibition in Parkinson's disease. Can J Neurol Sci 1997;24:133-136.
25. Young MS, Triggs WJ, Bowers D, et al. Stereotactic pallidotomy lengthens the transcranial magnetic cortical stimulation silent period in Parkinson's disease. Neurology 1997;49:1278-1283.
26. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
27. Defer GL, Widner H, Marié RM, Rémy P, Levivier M. Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov Disord 1999;14:572-584.
28. Oliveri M, Koch G, Torriero S, Caltagirone C. Increased facilitation of the primary motor cortex following 1 Hz repetitive transcranial magnetic stimulation of the contralateral cerebellum in normal humans. Neurosci Lett 2005;376:188-193.
29. Ugawa Y, Uesaka Y, Terao Y, et al. Magnetic stimulation over the cerebellum in humans. Ann Neurol 1995;37:703-713.
30. Parkinson Study Group. Evaluation of dyskinesias in a pilot, randomized, placebo-controlled trial of remacemide in advanced Parkinson disease. Arch Neurol 2001;58:1660-1668.
31. Reis J, Swayne OB, Vandermeeren Y, et al. Contribution of transcranial magnetic stimulation to the understanding of cortical mechanisms involved in motor control. J Physiol 2008;586:325-351.
32. McDonnell MN, Orekhov Y, Ziemann U. The role of GABA(B) receptors in intracortical inhibition in the human motor cortex. Exp Brain Res 2006;173:86-93.
33. Hoshi E, Tremblay L, Féger J, et al. The cerebellum communicates with the basal ganglia. Nat Neurosci 2005;8:1491-143.
34. Picconi B, Centonze D, Hakansson K, et al. Loss of bidirectional striatal synaptic plasticity in levodopa-induced dyskinesia. Nat Neurosci 2003;6:501-506.
35. Pascual-Leone A, Valls-Solé J, Brasil-Neto JP, et al. Akinesia in Parkinson's disease, II: effects of subthreshold repetitive transcranial motor cortex stimulation. Neurology 1994;44:892-898.
36. Khedr EM, Rothwell JC, Shawky OA, et al. Effect of daily repetitive transcranial magnetic stimulation on motor performance in Parkinson's disease. Mov Disord 2006;21:2201-2205.
37. Edwards MJ, Talelli P, Rothwell JC. Clinical applications of transcranial magnetic stimulation in patients with movement disorders. Lancet Neurol 2008;7:827-840.
38. Bäumer T, Lange R, Liepert J, et al. Repeated premotor rTMS leads to cumulative plastic changes of motor cortex excitability in humans. Neuroimage 2003;20:550-560.
39. Ito M. Control of mental activities by internal models in the cerebellum. Nat Rev Neurosci 2008;9:304-313.
40. Strafella AP, Ko JH, Monchi O. Therapeutic application of transcranial magnetic stimulation in Parkinson's disease: the contribution of expectation. Neuroimage 2006;31:1666-1672.